Quality of life in patients with intracranial tumors on the basis of Karnofsky's performance status
β Scribed by W. Sachsenheimer; W. Piotrowski; T. Bimmler
- Publisher
- Springer US
- Year
- 1992
- Tongue
- English
- Weight
- 344 KB
- Volume
- 13
- Category
- Article
- ISSN
- 0167-594X
No coin nor oath required. For personal study only.
β¦ Synopsis
This prospective clinical trial (1983)(1984)(1985)(1986)(1987)(1988)(1989) compares life-quality scores according to Karnofsky in patients with intra-cranial who had been operated upon. Karnofsky's performance status was evaluated during a follow-up period of 36 months. The patients were between 20 to 77 years of age; 132 patients had an astrocytoma grade III or IV; 42 patients with brain metastases were investigated; 72 had an astrocytoma grade I + II, and 144 had a meningioma.
The median survival in patients with astrocytomas grade III or IV was 12 months; a short period with nearly normal activity (Karnofsky score 75) was followed by rapid deterioration.
In patients with brain metastases, postoperatively the median functional ability reached its highest value three weeks after treatment and then decreased continuously (average score from 50-25). In patients with astrocytomas grade I and II, life-quality was reasonably good (mean score up to 75). The score was observed to increase slightly during the first year after treatment.
A performance status improvement up to 80 could be obtained in patients with meningiomas; however, 35% were left unfit for work.
π SIMILAR VOLUMES
## FOR THE UCLA SOLID TUMOR STUDY GROUP11 Serial assessments of Karnofsky performance status (KPS) and of the Functional Living Index-Cancer (FLIC) have been used to estimate the quality of life (QOL) of patients in a prospective, randomized trial of supportive care versus supportive care given wi
It has been observed that patients with metastatic brain lesions developed neurologic symptoms when given Corynebacterium parvum. To obtain more information in patients with intracranial mass lesions, intracranial pressures (ICP) were measured or observed in six patients undergoing C. parvum therapy